 NEW YORK, Nov. 30, 2020 GLOBE NEWSWIRE -- Intra-Cellular Therapies, Inc. Nasdaq:ITCI, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system CNS disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx Conference on Wednesday, December 2, 2020 at 9:15am ET. 